ABBVIE INC
Skyrizi
Resolved
307days ago
Approval decision · Sep 3, 2025
What's at stake
A final FDA approval decision on Skyrizi for its lead indication is expected Sep 3, 2025.
Primary source
· openFDA
verified 16h ago
“FDA approved Skyrizi (BLA761262) — sponsor ABBVIE INC; efficacy supplement (Efficacy); FDA action date 2025-09-03.”